Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aidan Synnott
CEO | Chief Executive Officer | 48 | 10/04/2025 |
Fabrice Viviani
CEO | Chief Executive Officer | - | 04/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 23/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 13/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 02/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 23/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 24/10/22 | Sell | Chief Technology Officer | 17,640 | 0.2576% | ||
| 24/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -0.14% | - | - | 105M | ||
| -2.54% | -2.84% | -1.90% | +14.52% | 48.93B | ||
| -0.40% | +1.03% | +439.20% | +499.20% | 45.01B | ||
| -1.42% | +2.30% | +45.46% | +19.36% | 44.07B | ||
| -1.22% | -2.31% | +12.40% | +71.48% | 40.73B | ||
| +0.53% | -1.36% | +16.04% | +48.23% | 33.52B | ||
| -0.21% | +9.14% | - | - | 17.77B | ||
| -0.35% | -1.56% | +22.59% | +116.19% | 16.5B | ||
| -1.01% | +0.50% | +15.83% | +27.98% | 14.67B | ||
| -1.65% | -1.03% | +77.75% | +37.63% | 13.77B | ||
| Average | -0.83% | +0.53% | +78.42% | +104.33% | 30.55B | |
| Weighted average by Cap. | -1.03% | +0.11% | +94.86% | +122.11% |
Employees
236
















